Sign in / Join Now
ETFs & Funds
undervalued considering the great results of Phase I. Presentations at ASH look really interesting.
Add a reply...
Latest StockTalks »
people get EPZM breaking news and analysis by email alert.
Get email alerts on EPZM »
Get latest price
From other sites
Epizyme Appoints Pamela Strode As Vice President, Regulatory Affairs And Quality Assurance
at TheStreet (Sep 29, 2016)
Epizyme Establishes Collaboration With Foundation Medicine To Support Tazemetostat Phase 2 Clinical Trial
at TheStreet (Sep 21, 2016)
First Week of EPZM May 2017 Options Trading
at TheStreet (Sep 20, 2016)
Epizyme Receives Milestone from Glaxo for Lymphoma Drug
at Zacks.com (Sep 16, 2016)
Epizyme Earns $6 Million Milestone Payment From GlaxoSmithKline For Initiation Of Clinical Development With First-in-Class PRMT5 Inhibitor
at TheStreet (Sep 15, 2016)